In a quality improvement team, the primary role of the facilitator is to promote effective group dynamics123. The facilitator, also known as a quality improvement coach, assists practices with coordinating their quality improvement activities and helps build capacity for those activities2. This reflects a systems-level approach to improving quality, safety, and implementation of evidence-based practices2. The facilitator encourages the views and opinions of the team, facilitates/assists with implementing QI activities, requests and uses appropriate resources, systems and support mechanisms, provides regular communication about QI activities, and reviews the progress of QI activities3.

Based on the matrix provided, ideas 2 and 5 should be addressed first because they are in the quadrant that represents both high impact and high feasibility. Prioritizing ideas that are both highly feasible and likely to have a significant impact ensures that the organization can quickly and effectively implement changes that will yield the most benefit.
* High Impact and High Feasibility: Ideas in this quadrant are typically the most promising because they are not only achievable (high feasibility) but also expected to produce meaningful improvements (high impact).
* Strategic Prioritization: Addressing these ideas first allows the team to generate quick wins, which can build momentum and support for further quality improvement efforts.
* Comparison to Other Options:
* A. 1 and 7: High impact but low feasibility-these ideas might be more challenging to implement and could require more resources or time.
* B. 3 and 4: Low impact and low feasibility-these ideas are neither easy to implement nor likely to have a significant effect, making them lower priorities.
* D. 6 and 8: High feasibility but low impact-while these ideas are easier to implement, their impact might be minimal, so they should not be the primary focus initially.
References: NAHQ materials on prioritization in quality improvement emphasize the importance of focusing on initiatives that combine high impact with high feasibility to optimize resource use and maximize outcomes.
=========

The performance measure for infection control, such as the number of primary bloodstream infections per
1000 central line days, is an example of a rate. In epidemiology and public health, a rate is a measure of the frequency with which an event, such as a new case of illness, occurs in a population over a period of time. The denominator is the population at risk; the numerator is the number of occurrences of disease. Here, the number of primary bloodstream infections isthe numerator, and the number of central line days is the denominator.
Therefore, this measure is a rate.

Latent conditions are underlying system vulnerabilities that increase the risk of errors but may not immediately cause harm, distinguishing them from active errors.
Option A (Specific unsafe acts that have adverse consequences): This describes active errors (e.g., wrong medication dose), not latent conditions.
Option B (Defects that may go undetected for long periods of time): This is the correct answer. The NAHQ CPHQ study guide states, "Latent conditions are systemic defects, such as poor equipment design or inadequate protocols, that remain undetected and increase error risk over time" (Domain 1). Examples include look-alike medications stored together.
Option C (Unintentional mistakes made by an individual): These are active errors, not latent system issues.
Option D (Errors having a direct and immediate effect on safety): These are active errors with immediate impact, not latent conditions.
CPHQ Objective Reference: Domain 1: Patient Safety, Objective 1.4, "Identify latent conditions contributing to errors," emphasizes recognizing systemic vulnerabilities. The NAHQ study guide notes, "Latent conditions are hidden system flaws that predispose to safety events" (Domain 1).
Rationale: Latent conditions are undetected system defects, aligning with CPHQ's focus on systemic safety risks.
Reference: NAHQ CPHQ Study Guide, Domain 1: Patient Safety, Objective 1.4.